1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AC009133.23 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA AC009336.19 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA AC015688.3 CTRPv2 pan-cancer AAC 0.17 7e-06
mRNA AC018902.1 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA AC024361.1 CTRPv2 pan-cancer AAC 0.15 7e-05
mRNA AC087350.1 CTRPv2 pan-cancer AAC 0.15 5e-05
mRNA AC090094.1 CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA AC096949.1 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA AC104534.3 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA AC104581.1 CTRPv2 pan-cancer AAC 0.12 0.0004
Download CSV